Skip to main content
Caplight Logo









BioSkepsis

BioSkepsis

Private
LarnacaHealthcare & Life Scienceshttps://bioskepsis.ai/

Total Funding Raised

$240,000

Company Overview

BioSkepsis is a biotechnology company that provides an AI-powered research intelligence platform for life-science and biomedical researchers to synthesize scientific literature.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Biotech Equipment, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium, Hardware Sales

AI Layer

Application

Keywords

biomedical research assistantAI research platformliterature review AIsemantic searchknowledge graphlab automationevidence synthesisAI drug discoverylaboratory roboticsscientific AIAI research agentAI for sciencebiotech softwarenatural language processingNLP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioSkepsis Comparables

Compare BioSkepsis with similar companies based on industry and business-model similarity.

BioSkepsis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EvidenceHunt
82%
Rodent2Human
79%
Causaly
78%

BioSkepsis Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Dimitris Kyriacou

Founder and CEO

Founding Team

BioSkepsis Filings

Explore SEC and related filing metadata, where available.

BioSkepsis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BioSkepsis's valuation, stock price, and market status.

Is BioSkepsis a public or private company?

BioSkepsis is a private company.

What is the current stock price of BioSkepsis?

BioSkepsis is a private company with no public stock price. Caplight tracks BioSkepsis's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is BioSkepsis worth (valuation)?

Valuation information for BioSkepsis is not publicly available.

Can I buy BioSkepsis stock?

BioSkepsis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BioSkepsis's last funding round?

Funding round information for BioSkepsis is not publicly available.

Who are the main investors in BioSkepsis?

Investor information for BioSkepsis is not publicly disclosed.

Will BioSkepsis IPO soon?

No public IPO plans have been announced for BioSkepsis.

How can I track BioSkepsis secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioSkepsis's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLarnaca
Employee Range6
Year Founded2018
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?